Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liberyx Therapeutics
Cambridge, Massachusetts, United States
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Liberyx Therapeutics is a pre-clinical stage biotechnology company dedicated to advancing RNA-based medicines through innovative delivery solutions. The company's proprietary Liberyx Delivery Platform (LDP) is designed to enable the effective delivery of RNA modalities, such as siRNA and mRNA, to extrahepatic tissues including the central nervous system and solid tumors. Founded by a team of seasoned industry experts from Alnylam and Genzyme, Liberyx is backed by leading life sciences investors like Atlas Venture. By addressing the fundamental challenge of tissue-specific delivery, the company seeks to unlock the full potential of genetic medicines for patients with high unmet medical needs. Their current pipeline focuses on neurological disorders and oncology.
- Therapeutic areas
- OncologyNeurology
- Modalities
- Small interfering RNAmRNA-based drugsRNA therapyLipid nanoparticle delivery therapy
- Industry
- Biotech
Beyond the preview
Go deeper on Liberyx Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Liberyx Therapeutics.